
LIC increases stake in Dr. Reddy’s to 9.69%
The Hindu
In over five months, it purchased more than 33.61 lakh shares in the market at an average price of ₹4,403.02 each
Life Insurance Corporation of India (LIC) increased its stake in Dr. Reddy’s Laboratories by 2% through open market purchase of more than 33.61 lakh shares over five months from October at an average price of ₹4,403.02 each.
Consequently, its shareholding in the drugmaker has increased 7.676% to 9.695% of the paid-up capital of the company, LIC informed the stock exchange. On Monday, Dr. Reddy’s shares closed at ₹4,383.65 apiece on the BSE.
The holding increased from 7.676% to 9.695%, an increase of 2.019 per centage points during the period from September 30 to March 10 at an average cost of ₹4,403.02, the insurance major said about its investment. Dr. Reddy’s also intimated the stock exchange about the change in LIC’s stake in the company.

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












